Open Access Journal

ISSN : 2456-1304 (Online)

International Journal of Engineering Research in Electronics and Communication Engineering(IJERECE)

Monthly Journal for Electronics and Communication Engineering

Open Access Journal

International Journal of Science Engineering and Management (IJSEM)

Monthly Journal for Science Engineering and Management

ISSN : 2456-1304 (Online)

Isolation, speciation and antifungal susceptibility testing of vaginal swab

Author : Dr Sendilkumar 1 Dr Sangeetha.S 2 Dr Lakshminarayana S.A 3 Dr Santhoshini Vaijinath 4

Date of Publication :26th June 2021

Abstract: Candida species is a normal commensal flora of human body inhabiting skin, mucous membranes and gastrointestinal tract but may be associated with superficial and deep-seated fungal infections.1,2 Candida species are responsible for various clinical infections ranging from mucocutaneous infection to life threatening invasive diseases along with increased resistance to antifungal drugs has made a serious concern. Resistance to antifungal agents has increased during the last decade. Thus, identification of Candida up to species level and its antifungal susceptibility testing has a significance in the management of Candida infections.3,4 Aim of the study is to isolate, characterize & to determine the anti-fungal susceptibility pattern of all Candida speciesisolatedfrom vaginal swab.

Reference :

    1.  Mohanty S, Xess I, Hasan F, Kapil A, Mittal S,Tolosa JE. Prevalence &susceptibility to fluconazole of Candida Species causing vulvovaginitis. Indian J Med Res 2007; 126:216–19.
    2. Mohanty S, Xess I, Hasan F, Kapil A, Mittal S, Tolosa JE. Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis. Indian J Med Res. 2007 Sep;126(3):216-9. PMID: 18037716.
    3. Baron EJ, Cassell GH, Duffy LB, Eschenbach JR, Greenwood SM, Harvey NE, et al. Laboratory diagnosis of female genital tract infections. In: Baron EJ, editor. Cumulative techniques and procedures in clinical microbiology (Cumitech) 17A. Washington, DC: ASM Press; 1993. pp. 1–28. [Google Scholar]
    4.  Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. Candida species: current epidemiology, pathogenicity, bioflm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10–24.
    5. Gullo A. Invasive fungal infections: the challenge continues. Drugs. 2009;69(Suppl 1):65–73.
    6. annon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, Tanabe K, Niimi M, Gofeau A, Monk BC. Efux mediated antifungal drug resistance. Clin Microbiol Rev. 2009;22:291–321.
    7.  ElFeky DS, Gohar NM, El-Seidi EA, Ezzat MM, AboElew SH. Species identifcation and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal candidiasis. Alex Med J. 2016;52:269– 77. 8
    8. Jayalakshmi L, RatnaKumari G, Samson SH. Isolation, speciation and antifungal susceptibility testing of candida from clinical specimens at a tertiary care hospital. Sch J App Med Sci. 2014;2:3193–8.
    9.  Jha BJ, Dey S, Tamang MD, Joshy ME, Shivananda PG, Brahmadatan KN. Characterization of Candida species isolated from cases of lower respiratory tract infection. Kathmandu Univ Med J. 2006;4:290–4.
    10. Sajjan AC, Mahalakshmi VV, Hajare V. Prevalence and antifungal susceptibility of Candida species isolated from patients attending tertiary care hospital. IOSR J Dent Med Sci. 2014;13:44–9.

Recent Article